https://biotechmorning.com/news/oral-infigratinib-achondroplasia-fda-priority-review Biotech Morning en 2026-10-06T14:16:21.452Z The Pill That Could Replace Your Kid's Daily Shot https://biotechmorning.com/news/csl-alentis-claudin-1-deal Biotech Morning en 2026-10-06T14:15:39.360Z CSL Just Bet $1.6 Billion on a Protein Nobody's Heard Of https://biotechmorning.com/news/sarepta-elevidys-gene-therapy-fda-investigation-deaths Biotech Morning en 2026-10-06T14:14:54.967Z The Gene Therapy That Was Supposed to Be a Miracle https://biotechmorning.com/news/novartis-abogen-mRNA-deal Biotech Morning en 2026-10-06T14:14:11.982Z Novartis Just Bet $7.8 Billion That mRNA Can Do Way More Than Vaccines https://biotechmorning.com/news/nobel-prize-optogenetics-brain-light Biotech Morning en 2026-10-06T14:13:24.868Z The Nobel Prize Just Went to Scientists Who Learned to Control the Brain With Light https://biotechmorning.com/news/fda-public-input-ibogaine-trial-design Biotech Morning en 2026-10-06T14:12:36.150Z The FDA Just Asked the Internet to Help Design a Drug Trial https://biotechmorning.com/news/forbion-2-3-billion-european-biotech-fund Biotech Morning en 2026-10-06T14:11:52.090Z Europe's Biggest Biotech Bet Just Got a Lot Bigger https://biotechmorning.com/news/fda-clears-app-treat-schizophrenia-negative-symptoms Biotech Morning en 2026-10-06T14:11:11.262Z The FDA Just Cleared a Phone App to Treat Schizophrenia. Seriously. https://biotechmorning.com/news/shionogi-intrabio-2-billion-rare-disease-acquisition Biotech Morning en 2026-10-06T14:10:21.153Z Why Shionogi Just Bet $2 Billion on a Tiny Texas Biotech https://biotechmorning.com/news/epcoritamab-frontline-dlbcl-phase-3-results Biotech Morning en 2026-10-06T14:09:35.397Z The Drug That Could Rewrite How We Treat the Most Common Blood Cancer https://biotechmorning.com/news/astrazeneca-2-billion-summit-therapeutics-ivonescimab-2 Biotech Morning en 2026-10-06T14:08:51.885Z AstraZeneca Just Bet $2 Billion on a Drug It Doesn't Even Own https://biotechmorning.com/news/thymus-tolerance-bio-tanabe-560-million-deal Biotech Morning en 2026-10-05T14:16:04.014Z The Organ Everyone Forgot Is Suddenly Worth $560 Million https://biotechmorning.com/news/ge-healthcare-sofie-biosciences-acquisition-cyclotrons Biotech Morning en 2026-10-05T14:15:21.103Z Why GE HealthCare Just Paid $945 Million for a Fleet of Cyclotrons https://biotechmorning.com/news/sanofi-regeneron-8-billion-immunology-deal Biotech Morning en 2026-10-05T14:14:34.948Z Pharma's Most Famous Couple Just Renewed Their Vows for $8 Billion https://biotechmorning.com/news/vaxcyte-vax-31-picks-fight-with-pfizer-vaccine Biotech Morning en 2026-10-05T14:13:52.589Z The Tiny Biotech That Just Picked a Fight With Pfizer's Biggest Vaccine https://biotechmorning.com/news/genentech-alector-al050-brain-delivery-deal Biotech Morning en 2026-10-05T14:13:04.516Z Why Genentech Just Bet $1.3 Billion on a Brain Delivery Trick https://biotechmorning.com/news/enveda-311m-series-e-natural-product-ai Biotech Morning en 2026-10-05T14:12:18.167Z The $311M Bet That Nature Is a Better Chemist Than We Are https://biotechmorning.com/news/novo-nordisk-denecimig-fda-delay-manufacturing Biotech Morning en 2026-10-05T14:11:29.070Z Novo Nordisk's Hemophilia Drug Was Ready. The Factory Wasn't. https://biotechmorning.com/news/bridgebio-bbp-418-cardiac-data-lgmd Biotech Morning en 2026-10-05T14:10:43.595Z The Rare Disease Drug That's Fixing Hearts Nobody Knew Were Breaking https://biotechmorning.com/news/europe-pharma-ceos-joint-letter-biotech-competitiveness Biotech Morning en 2026-10-05T14:09:54.741Z Europe's Pharma Giants Just Sent a 911 Call to Brussels https://biotechmorning.com/news/daiichi-sankyo-merck-adc-fda-withdrawal Biotech Morning en 2026-10-05T14:09:13.561Z The $4 Billion ADC Bet That Just Hit a Wall https://biotechmorning.com/news/rna-drug-sefaxersen-iga-nephropathy-phase-3 Biotech Morning en 2026-10-05T14:08:27.482Z The RNA Drug That Just Crashed Kidney Disease's Biggest Party